We describe a case of relapsed paratyphoid fever in which the isolate had reduced susceptibility to ciprofloxacin due to a rare mutation within the gyrA gene.
A 47-year-old resident of the United Kingdom presented with fever, abdominal discomfort, and altered bowel habit 3 months after returning from India, where she had visited Hyderabad, Delhi, and Mumbai. Salmonella enterica serotype Paratyphi A was isolated from her stool. She received a 10-day course of ciprofloxacin (1 g per day) with some apparent clinical improvement in her condition. However, 1 week after completing therapy, she presented to our hospital with recurrent symptoms and worsening lower back pain. S. Paratyphi A was subsequently isolated from blood cultures, and relapsed paratyphoid fever was diagnosed. Although the isolate appeared to be susceptible to ciprofloxacin on standard disc diffusion testing [1] , it was resistant to nalidixic acid. This finding prompted measurement of the MIC of ciprofloxacin by E-test (AB Biodisk), which revealed reduced susceptibility (MIC, 0.25 mg/mL). The patient's original stool isolate, processed at a different hospital, was not tested with a nalidixic acid disc. Both isolates were sensitive to ceftriaxone, ampicillin, gentamicin, trimethoprim, and imipenem.
Although the relapse of this patient's disease was originally believed to be caused by the inappropriate prescription of cip-rofloxacin, the patient's worsening back pain also suggested vertebral osteomyelitis. Plain spinal radiography, MRI, and technetium bone scanning revealed no evidence of deep-seated infection. Two days after a normal gadolinium-enhanced spinal MRI scan, an 18 fluorodeoxyglucose positron emission tomography scan ( 18 fluorodeoxyglucose is a glucose analogue known to be taken up by activated macrophages and neutrophils) revealed clear evidence of vertebral osteomyelitis ( figure 1A ) and an aortitis (figure 1B) that was unsuspected and undetectable clinically. Treatment was initiated with 3 weeks of intravenous ceftriaxone (2 g per day) and followed by 2 months of treatment with oral ofloxacin (800 mg per day) plus amoxicillin (3 g per day), after which complete clinical recovery was achieved. Repeat positron emission tomography scans showed considerable improvement of both aortitis and osteomyelitis at 6 weeks and resolution of changes by 3 months.
Globally, 75% of cases of enteric fever are caused by Salmonella enterica serotype Typhi. S. Paratyphi A is increasingly isolated in India [2] , and in some regions of China it is emerging as the most frequent cause of enteric fever [3] . A significant minority of all patients with enteric fever experience relapse after treatment [4] . Relapsed disease can cause significant morbidity, an increased mortality, and may contribute to the development of drug resistance. However, the causes of relapse can be difficult to identify.
An important factor in treatment failure is unrecognized antibiotic resistance. Reduced susceptibility to ciprofloxacin has been recognized in both S. Typhi [5] and S. Paratyphi A [5] , especially in isolates from India and elsewhere in Asia where the incidence of antibiotic resistance continues to rise. Resistance to nalidixic acid is recognized as a good predictor of a reduced susceptibility to ciprofloxacin [5] and treatment failure with fluoroquinolones [6] .
Such low-level resistance is often associated with mutation within the quinolone-resistance determining region of the bacterial gyrA gene [6] . Amplification by PCR of this isolate's quinolone-resistance determining region was performed using the oligonucleotides gyrA-P1 (TGTCCGAGATGGCCTGA-AGC) and gyrA-P2 (TACCGTCATAGTTATCCACG) [7] . Sequencing was performed using an ABI Prism dye terminator cycle sequencing kit (Perkin Elmer) and an ABI 3730 automated sequencer [8] . This revealed a single point mutation in the gyrA gene (Ser83Tyr), compared with a susceptible isolate. Although reported frequently in other serotypes of Salmonella [9] , this mutation is rarely associated with reduced quinolone susceptibility in S. Paratyphi A [10] . This case reinforces the importance of routine testing for both S. Typhi and S. Paratyphi A isolates for nalidixic acid resistance and the need for formal determination of the MIC for the quinolone chosen as treatment, particularly in individuals who have travelled to areas of the world where these organisms have been observed to have increasing drug resistance. If the MIC of ciprofloxacin is у0.125mg/mL, consideration should be given to alternative treatments, including cephalosporins [11] , azithromycin, or newer quinolones [12] .
Reduced ciprofloxacin sensitivity may not be the only factor in the relapse of this patient's illness. In 1 study of nalidixic acid-resistant S. Typhi isolates [6] , only a minority of cases treated with short-course ofloxacin relapsed, suggesting that factors other than drug sensitivity are also important. Undiagnosed deep-seated disease is likely to be one such factor. In this case, 18 fluorodeoxyglucose positron emission tomography imaging was more sensitive than MRI for the detection of osteomyelitis, and this supports experiences in different settings with other pathogens [13, 14] . More importantly, perhaps, is that positron emission tomography imaging was able to detect a clinically unsuspected aortitis. Aortitis is often very hard to detect clinically and may only be identified postmortem. CT scanning and MRI are able to detect aneurismal dilatation, but such infections are well established, and often major surgery and prolonged courses of antibiotics are required [15] , with the estimated mortality in nontyphoidal salmonellosis determined to be 14%-60% [16] . Early recognition and treatment of aortitis could prevent disease relapse, disease progression, and even death.
These images not only provide a novel insight into disease pathogenesis and relapse, but also show that where available, such imaging could influence clinical management and provide a rational basis for deciding the duration of treatment. Taken together, the radiological, clinical, and microbiological details provide unusual insight into the complexity of disease relapse for a single patient.
